Investors don't fully appreciate Gilead Sciences' (GILD) leadership in HIV treatment, an analyst said Friday as he upgraded GILD stock.
X
Gilead is a key...
Stocks inched slightly upward Friday, with the Nasdaq shaking off an Apple-fueled (AAPL) slide, after officials hinted the Federal Reserve could hold off...